Stay updated on NSCLC Combination Therapy Clinical Trial
Sign up to get notified when there's something new on the NSCLC Combination Therapy Clinical Trial page.

Latest updates to the NSCLC Combination Therapy Clinical Trial page
- CheckyesterdayChange DetectedNew site identity and address added, contact options expanded, status updated to Active/not Recruiting, and revision advanced to v3.0.2, replacing the previous v3.0.1 and removing the old Vilniaus Miestas data.SummaryDifference1%
- Check8 days agoChange DetectedThe page has been updated to reflect that the study now has 179 locations and is actively recruiting, with new contact information provided for the Study Coordinator in Oceanside, California.SummaryDifference0.9%
- Check16 days agoChange DetectedThe webpage has undergone significant updates, including the addition of numerous facility locations across various countries, as well as the reintroduction of the drug Sacituzumab Govitecan. Several previously listed locations and related topics have been removed.SummaryDifference21%
- Check23 days agoChange DetectedThe page has updated its recruitment status to 'Active, not recruiting' and removed several past dates, indicating a shift in the project's current status and timeline.SummaryDifference0.6%
- Check30 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.0%
- Check37 days agoChange DetectedThe web page has been updated from version 2.16.10 to version 2.16.11.SummaryDifference0.0%
Stay in the know with updates to NSCLC Combination Therapy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the NSCLC Combination Therapy Clinical Trial page.